Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro
Gc. Riise et al., Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro, RESPIRATION, 67(5), 2000, pp. 552-558
Background: Bacterial adherence to mucosal and epithelial cell structures i
s of importance for the persistence of bacteria in the airways. Cigarette s
moking and chronic bronchitis are associated with increased bacterial adher
ence. N-Acetylcysteine (NAC) medication reduces the number of infectious ex
acerbations in patients with chronic bronchitis, and NAC medication has bee
n associated with low intrabronchial bacterial numbers. Objective: We inves
tigated whether NAC influences bacterial adherence as a possible mechanism
behind its clinical effects. Methods: Highly adhering test strains of Strep
tococcus pneumoniae and Haemophilus influenzae were used to investigate the
influence of four pharmacological compounds on adherence to oropharyngeal
epithelial cells in vitro. Adhesion assays were performed both during short
-term exposure to, as well as after long-time incubation with, NAG, lidocai
ne, hydrocortisone and terbutaline at concentrations not inhibiting bacteri
al growth. Results: Only NAC showed a significant inhibitory effect on adhe
sion of H. influenzae during short-term incubation. After long-term incubat
ion, both NAC and hydrocortisone inhibited bacterial adhesion for both stra
ins in a dose-dependent manner. When NAC's effect on three different strain
s of S. pneumoniae and four strains of H. influenzae was studied, inhibitio
n of bacterial adhesion was found for th ree strains of each species. Concl
usions: NAC lowers bacterial adhesion in vitro to oropharyngeal epithelial
cells in doses equivalent to that is being used clinically. This effect mig
ht be a contributory mechanism behind the reduction of infectious exacerbat
ions in chronic bronchitis patients. Copyright (C) 2000 S. Karger AG, Basel
.